| Bioactivity | Sucunamostat (SCO-792) hydrochloride is an orally active and reversible enteropeptidase inhibitor with IC50s of 4.6 nM and 5.4 nM for rat enteropeptidase and human enteropeptidase, respectively. Sucunamostat hydrochloride can slowly dissociate from enteropeptidase in vitro and inhibit protein digestion in vivo[1]. | ||||||||||||
| Target | IC50: 4.6 nM (rat enteropeptidase), 5.4 nM (human enteropeptidase) | ||||||||||||
| In Vivo | Sucunamostat hydrochloride (10 和 30 mg/kg；口服，单次剂量) 有效且剂量依赖性地抑制大鼠口服蛋白质剂量诱导的血浆支链氨基酸 (BCAA) 升高[1]。Sucunamostat hydrochloride 在雄性 Sprague-Dawley 大鼠体内的药代动力学参数[1] | ||||||||||||
| Name | Sucunamostat hydrochloride | ||||||||||||
| Formula | C22H23ClN4O8 | ||||||||||||
| Molar Mass | 506.89 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Sasaki M, et al. Discovery and characterization of a small-molecule enteropeptidase inhibitor, SCO-792. Pharmacol Res Perspect. 2019 Sep 4;7(5):e00517. |
Sucunamostat hydrochloride
CAS: F: C22H23ClN4O8 W: 506.89
Sucunamostat (SCO-792) hydrochloride is an orally active and reversible enteropeptidase inhibitor with IC50s of 4.6 nM a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.